Geode Capital Management LLC increased its position in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) by 27.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 630,369 shares of the company's stock after buying an additional 136,518 shares during the quarter. Geode Capital Management LLC owned 1.70% of Celcuity worth $9,401,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. nVerses Capital LLC acquired a new position in Celcuity during the 3rd quarter worth approximately $33,000. Prospera Private Wealth LLC acquired a new position in Celcuity during the third quarter worth $35,000. Values First Advisors Inc. bought a new position in Celcuity in the third quarter valued at $86,000. Quest Partners LLC grew its position in Celcuity by 31.3% in the second quarter. Quest Partners LLC now owns 5,788 shares of the company's stock valued at $95,000 after purchasing an additional 1,379 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in Celcuity in the 3rd quarter valued at $119,000. Institutional investors and hedge funds own 63.33% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on CELC shares. Needham & Company LLC restated a "buy" rating and set a $23.00 price objective on shares of Celcuity in a research note on Friday, November 15th. HC Wainwright reissued a "buy" rating and set a $27.00 price target on shares of Celcuity in a research report on Friday, November 15th. Finally, Stifel Nicolaus raised their price target on Celcuity from $39.00 to $42.00 and gave the company a "buy" rating in a research note on Monday, October 7th. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $29.17.
View Our Latest Stock Analysis on Celcuity
Celcuity Stock Performance
Celcuity stock traded up $0.04 during mid-day trading on Thursday, hitting $13.13. 141,692 shares of the company's stock traded hands, compared to its average volume of 280,366. The company has a debt-to-equity ratio of 0.65, a current ratio of 10.35 and a quick ratio of 10.36. The firm has a 50 day simple moving average of $13.63 and a two-hundred day simple moving average of $15.29. Celcuity Inc. has a fifty-two week low of $11.51 and a fifty-two week high of $22.19. The stock has a market cap of $487.52 million, a price-to-earnings ratio of -5.03 and a beta of 0.74.
About Celcuity
(
Free Report)
Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.
See Also
Before you consider Celcuity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celcuity wasn't on the list.
While Celcuity currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
